Standout Papers

Trial of Upadacitinib and Adalimumab for Psoriatic Arthritis 2021 2026 2022 2024170
  1. Trial of Upadacitinib and Adalimumab for Psoriatic Arthritis (2021)
    Iain B. McInnes, J. Anderson et al. New England Journal of Medicine

Immediate Impact

2 from Science/Nature 73 standout
Sub-graph 1 of 22

Citing Papers

Inflammatory response of nanoparticles: Mechanisms, consequences, and strategies for mitigation
2024 Standout
Therapeutic advances in rheumatoid arthritis
2024 Standout
2 intermediate papers

Works of Patrick Zueger being referenced

Trial of Upadacitinib and Adalimumab for Psoriatic Arthritis
2021 Standout
Upadacitinib for psoriatic arthritis refractory to biologics: SELECT-PsA 2
2020

Author Peers

Author Last Decade Papers Cites
Patrick Zueger 440 266 371 34 694
J.M. Kremer 538 266 190 26 780
Eva Salgado 492 139 253 22 786
P. M. Houtman 468 167 217 25 746
Victor Ginsberg 277 178 149 21 641
Maria Gabriella Raimondo 390 150 191 32 695
Vasco C. Romão 374 117 291 42 824
Alice Klinkhoff 490 158 185 30 788
H. S. Goei Thè 488 129 156 29 701
Álvaro Danza 528 80 276 25 731
Sujith Subesinghe 373 155 157 26 691

All Works

Loading papers...

Rankless by CCL
2026